drugset / Trial / NCT02917200
Safety and Efficacy Study of Different DAV132 Dose Regimens in Healthy Volunteers
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to evaluate whether different DAV132 dose regimens are safe and effective for capturing fecal residues of moxifloxacin in healthy volunteers.
Timeline
- Start
- 2016-05-11
- Primary completion
- 2016-12-02
- Completion
- 2016-12-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Moxifloxacin | Small molecule | 400 mg | Oral |
Indications
No indication recorded.